Federated Hermes Inc. Lowers Holdings in Omnicell, Inc. (NASDAQ:OMCL)

Federated Hermes Inc. reduced its stake in Omnicell, Inc. (NASDAQ:OMCL - Free Report) by 75.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 77,861 shares of the company's stock after selling 243,690 shares during the period. Federated Hermes Inc. owned approximately 0.17% of Omnicell worth $2,930,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the stock. Strs Ohio grew its stake in shares of Omnicell by 28.2% in the fourth quarter. Strs Ohio now owns 5,000 shares of the company's stock worth $188,000 after acquiring an additional 1,100 shares during the last quarter. Louisiana State Employees Retirement System purchased a new stake in shares of Omnicell during the fourth quarter valued at $854,000. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Omnicell by 3.2% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 638,646 shares of the company's stock valued at $24,032,000 after buying an additional 19,601 shares during the last quarter. Arkadios Wealth Advisors boosted its position in shares of Omnicell by 6.2% during the fourth quarter. Arkadios Wealth Advisors now owns 22,985 shares of the company's stock valued at $865,000 after buying an additional 1,341 shares during the last quarter. Finally, Trust Point Inc. purchased a new stake in shares of Omnicell during the fourth quarter valued at $342,000. 97.70% of the stock is owned by hedge funds and other institutional investors.

Omnicell Stock Performance

Shares of NASDAQ OMCL traded up $0.73 during trading on Friday, hitting $27.86. The company had a trading volume of 393,193 shares, compared to its average volume of 374,540. The stock has a 50 day simple moving average of $27.67 and a 200 day simple moving average of $32.15. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.22 and a current ratio of 2.52. Omnicell, Inc. has a 12 month low of $25.69 and a 12 month high of $77.14. The firm has a market capitalization of $1.28 billion, a P/E ratio of -61.91 and a beta of 0.76.

Omnicell (NASDAQ:OMCL - Get Free Report) last released its earnings results on Thursday, February 8th. The company reported $0.12 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.22. Omnicell had a positive return on equity of 3.43% and a negative net margin of 1.78%. The firm had revenue of $258.85 million during the quarter, compared to analysts' expectations of $256.00 million. As a group, analysts anticipate that Omnicell, Inc. will post 0.09 earnings per share for the current year.

Analyst Ratings Changes

OMCL has been the topic of several recent analyst reports. Benchmark dropped their price objective on Omnicell from $42.00 to $38.00 and set a "buy" rating on the stock in a research report on Friday, February 9th. Barclays initiated coverage on Omnicell in a research report on Wednesday, January 3rd. They set an "underweight" rating and a $33.00 price objective on the stock. Finally, Wells Fargo & Company dropped their price objective on Omnicell from $28.00 to $26.00 and set an "equal weight" rating on the stock in a research report on Friday, February 9th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, Omnicell has a consensus rating of "Hold" and a consensus price target of $42.20.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.